About Linus Biotechnology
Linus Biotechnology is a company based in New York (United States) founded in 2020 by Paul Curtin and Christine Austin. Linus Biotechnology has raised $47.65 million across 4 funding rounds from investors including Yac, GreatPoint Ventures and BowX Acquisition Corp. Linus Biotechnology operates in a competitive market with competitors including Genomics, Depixus, Seven Bridges Genomics, Ingenuity Systems and BC Platforms, among others.
- Headquarter New York, United States
- Founders Paul Curtin, Christine Austin
- SectorsHealthcare
- Website linusbio.com
- Social LinkedIn X
- Total Equity Funding$47.65M (USD)
in 4 rounds
- Latest Funding Round$6.15M (USD), Series A
Jul 2024
- InvestorsYac
& 4 more
Funding Insights of Linus Biotechnology
Linus Biotechnology has successfully raised a total of $47.65M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.15 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $47.65M
- Total Rounds 4
- Last Round Series A — $6.15M
- First Round $17.5M
(Mar 2022)
- Investors Count 5
All 4 funding rounds of Linus Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $6.15M | Series A | – | – | – |
| May 2023 | $8M | Series A | – | – | |
| Jan 2023 | $16M | Series A | – | GreatPoint Ventures, Bow Capital | |
| Mar 2022 | $17.5M | Series A | – | – | – |
5 investors in total: 4 institutional and 1 angel.
Investors in Linus Biotechnology
Linus Biotechnology has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Yac, GreatPoint Ventures and BowX Acquisition Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on early-stage big data, health tech, AI, food tech, and multiple sectors | – | gpv.com | San Francisco, United States | |
Venture capital firm linking startups to University of California networks. | 2020 | bowcapital.com | Menlo Park, United States | |
- | – | investdivergent.com | - | |
Cloud-based voice messaging solutions are offered for remote teams. | 2018 | yac.com | Kissimmee, United States | |
NS Nicole Shanahan | Tech entrepreneur, philanthropist, and angel investor in innovative startups. | – | unknown_2c5dda58c2034b2f9 | - |
Investor details for Linus Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Linus Biotechnology
13 people are tracked at Linus Biotechnology (11 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Paul Curtin | Co-Founder | Leadership |
Christine Austin | Co-Founder | Leadership |
Manish Arora | Founder and CEO | Leadership |
Ronak Kadakia | Chief Operating Officer | Leadership |
Sheila Kennedy | Vp, Market Access And Marketing | Leadership |
Kathy Ryan | Chief Financial Officer | Leadership |
Sophie Dessalle | Chief Regulatory Officer | Leadership |
Aviad Yitshak - Sade | Director, Marketing Communications | Leadership |
Victoria Polyanskaya | Vp, Business Development, EMEA | Leadership |
Ronak K. | Chief Operations Officer | Leadership |
Luis M. Otero | Director, Commercial Analytics And Alliances | Leadership |
Andrew Warner | General Counsel | Team |
Lesly Pichardo | Senior Manager, Customer Care | Team |
Complete people profiles for Linus Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Linus Biotechnology
3 dated milestones of Linus Biotechnology across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Linus Biotechnology is founded.
- Funding First funding round of $17.5M.
- Funding Latest funding round, Series A, of $6.1M.
Competitors of Linus Biotechnology
Linus Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomics, Depixus, Seven Bridges Genomics, Ingenuity Systems and BC Platforms, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genomics.com | 2014 | Oxford, United Kingdom | $115.54M | – | Genomic risk assessment and prevention platform is provided. | |
| depixus.com | 2012 | Paris, France | $34.52M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| bcplatforms.com | 1997 | Zurich, Switzerland | $47.15M | 8 | Platforms for genomic data analysis and management are provided. | |
| deepgenomics.com | 2015 | Toronto, Canada | $237.96M | – | Machine learning is utilized for precision medicine and genetic diagnostics. | |
| envisagenics.com | 2014 | Long Island, United States | $46.78M | – | RNA splicing therapeutics are discovered and developed through AI-driven biotechnology. | |
| idbydna.com | 2014 | Salt Lake, United States | $29M | – | Developer of search engine to identify pathogens in sample | |
| seqone.com | 2017 | Montpellier, France | $48.79M | – | Bioinformatics tools for genome sequencing data analysis are provided. | |
| hexagonbio.com | 2017 | Menlo Park, United States | $205.6M | 34 | Bioinformatics tools are provided for analyzing microbial genomic sequencing data. |
Detailed competitors of Linus Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Linus Biotechnology
The website of Linus Biotechnology (linusbio.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 5.1% vs previous month
Latest news on Linus Biotechnology
Complete news archive for Linus Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Linus Biotechnology
10 companies that operate in the same segment as Linus Biotechnology (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Linus Biotechnology
Linus Biotechnology was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Linus Biotechnology is headquartered in New York, United States. It is registered at New York, New York, United States.
Linus Biotechnology is a funded company, having raised a total of $47.65M across 4 funding rounds to date. The company's 1st funding round was a Series A of $17.5M, raised on Mar 2022.
Developer of diagnostic tests for central nervous system and gastrointestinal disorders. The company offers StrandDx ASD, a non-invasive diagnostic aid for Autism Spectrum Disorder. The companys pipeline comprises precision exposome medicine biomarkers and target discovery across gastroenterology, renal disease and oncology.
Linus Biotechnology's top competitors include Depixus, Ingenuity Systems and Envisagenics.
Linus Biotechnology has 5 investors. Key investors include Yac, GreatPoint Ventures, BowX Acquisition Corp, Divergent Investments, and Nicole Shanahan.